{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:31:21Z","timestamp":1765438281718},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,3,10]],"date-time":"2012-03-10T00:00:00Z","timestamp":1331337600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s10875-012-9679-y","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T05:01:55Z","timestamp":1331269315000},"page":"786-793","source":"Crossref","is-referenced-by-count":22,"title":["Glucocorticoid Sensitivity and Proinflammatory Cytokines Pattern in Pemphigus"],"prefix":"10.1007","volume":"32","author":[{"given":"Rosangela Soares","family":"Chriguer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria","family":"Roselino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,10]]},"reference":[{"key":"9679_CR1","doi-asserted-by":"crossref","unstructured":"Grando SA. Pemphigus autoimmunity: Hypotheses and realities. Autoimmunity. 2011. Sep 23. [Epub ahead of print].","DOI":"10.3109\/08916934.2011.606444"},{"key":"9679_CR2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-92-3-396","volume":"92","author":"AR Ahmed","year":"1980","unstructured":"Ahmed AR, Graham J, Jordan RE, Provost TT. Pemphigus: current concepts. Ann Intern Med. 1980;92:396\u2013405.","journal-title":"Ann Intern Med."},{"key":"9679_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/1523-1747.ep12316695","volume":"105","author":"H Shimizu","year":"1995","unstructured":"Shimizu H, Masunaga T, Ishiko A, Kikuchi A, Hashimoto T, Nishikawa T. Pemphigus vulgaris and pemphigus foliaceus sera show an inversely graded binding pattern to Extracellular regions of desmosomes in different layers of human epidermis. J Invest Dermatol. 1995;105:153\u201359.","journal-title":"J Invest Dermatol."},{"key":"9679_CR4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","volume":"67","author":"M Amagai","year":"1991","unstructured":"Amagai M, Klaus-Kovtum V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991;67:869\u201377.","journal-title":"Cell."},{"key":"9679_CR5","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1084\/jem.160.5.1509","volume":"160","author":"L Koulu","year":"1984","unstructured":"Koulu L, Kusumi A, Steinberg MS, Klaus-Kovtun V, Stanley JR. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med. 1984;160:1509\u201318.","journal-title":"J Exp Med."},{"key":"9679_CR6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.4049\/jimmunol.136.4.1227","volume":"136","author":"JR Stanley","year":"1986","unstructured":"Stanley JR, Koulu L, Klaus-Kovtum V, Steinberg MS. A monoclonal antibody to the desmosomal glycoprotein desmoglein 1 binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol. 1986;136:1227\u201330.","journal-title":"J Immunol."},{"key":"9679_CR7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","volume":"58","author":"DF Murrell","year":"2008","unstructured":"Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, Borradori L, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008;58:1043\u201346.","journal-title":"J Am Acad Dermatol."},{"key":"9679_CR8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S0036-46652001000200001","volume":"43","author":"MP Chiossi","year":"2001","unstructured":"Chiossi MP, Roselino AM. Endemic Pemphigus foliaceus (\u201cFogo selvagem\u201d): a series from the Northeastern region of the State of S\u00e3o Paulo, Brazil, 1973\u20131998. Rev Inst Med Trop SP. 2001;43:59\u201362.","journal-title":"Rev Inst Med Trop SP."},{"key":"9679_CR9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00403-003-0434-3","volume":"295","author":"I Zuccolotto","year":"2003","unstructured":"Zuccolotto I, Roselino AM, Ramalho LN, Zucoloto S. Apoptosis and p63 expression in the pathogenesis of bullous lesions of endemic pemphigus foliaceus. Arch Dermatol Res. 2003;295:284\u201386.","journal-title":"Arch Dermatol Res."},{"key":"9679_CR10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1590\/S0100-879X2004000300008","volume":"37","author":"MP Chiossi","year":"2004","unstructured":"Chiossi MP, Costa RS, Roselino AM. Dermal dendritic cell number correlates with serum autoantibody titers in Brazilian pemphigus foliaceus patients. Braz J Med Biol Res. 2004;37:337\u201341.","journal-title":"Braz J Med Biol Res."},{"key":"9679_CR11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2133.2005.06427.x","volume":"152","author":"TB Rosatelli","year":"2005","unstructured":"Rosatelli TB, Roselino AM, Dellalibera-Joviliano R, Reis ML, Donadi EA. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvage). Br J Dermatol. 2005;152:650\u201357.","journal-title":"Br J Dermatol."},{"key":"9679_CR12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10875-011-9597-4","volume":"32","author":"H Zhu","year":"2012","unstructured":"Zhu H, Chen Y, Zhou Y, Wang Y, Zheng J, Pan M. Cognate Th2-B cell interaction is essential for the autoantibodies production in pemphigus vulgaris. J Clin Immunol. 2012;32:114\u201323.","journal-title":"J Clin Immunol."},{"key":"9679_CR13","first-page":"383","volume":"8","author":"L D\u2019Auria","year":"1997","unstructured":"D\u2019Auria L, Bonifati C, Mussi A, D\u2019Agosto G, De Simone C, Giacalone B, et al. Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity. Eur Cytokine Netw. 1997;8:383\u201387.","journal-title":"Eur Cytokine Netw."},{"key":"9679_CR14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/CDLI.10.5.741-743.2003","volume":"10","author":"DB Rocha-Rodrigues","year":"2003","unstructured":"Rocha-Rodrigues DB, Paschoini G, Pereira SAL, dos Reis MA, de Paula Antunes Teixeira V, Rodrigues J\u00fanior V. High levels of interleukin-1 in patients with endemic pemphigus foliaceus. Clin Diagn Lab Immunol. 2003;10:741\u201343.","journal-title":"Clin Diagn Lab Immunol."},{"key":"9679_CR15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.jid.5700527","volume":"127","author":"H Takahashi","year":"2007","unstructured":"Takahashi H, Amagai M, Tanikawa A, Suzuki S, Ikeda Y, Nishikawa T, et al. T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris. J Invest Dermatol. 2007;127:324\u201330.","journal-title":"J Invest Dermatol"},{"key":"9679_CR16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2249.2008.03638.x","volume":"152","author":"JN Stern","year":"2008","unstructured":"Stern JN, Keskin DB, Barteneva N, Zuniga J, Yunis EJ, Ahmed AR. Possible role of natural killer cells in pemphigus vulgaris \u2013 preliminary observations. Clin Exp Immunol. 2008;152:472\u201381.","journal-title":"Clin Exp Immunol."},{"key":"9679_CR17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/08916934.2011.606446","volume":"45","author":"LR Zakka","year":"2012","unstructured":"Zakka LR, Fradkov E, Keskin DB, Tabansky I, Stern JN, Ahmed AR. he role of natural killer cells in autoimmune blistering diseases. Autoimmunity. 2012;45:44\u201354.","journal-title":"Autoimmunity."},{"key":"9679_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","volume":"132","author":"JC Bystryn","year":"1996","unstructured":"Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol. 1996;132:203\u201312.","journal-title":"Arch Dermatol."},{"key":"9679_CR19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1210\/edrv-17-3-245","volume":"17","author":"CM Bamberger","year":"1996","unstructured":"Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev. 1996;17:245\u201361.","journal-title":"Endocr Rev."},{"key":"9679_CR20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF03401643","volume":"2","author":"M Castro","year":"1996","unstructured":"Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E, et al. The non-ligand binding \u00df-isoform of the human glucocorticoid receptor (hGR\u00df): tissue levels, mechanism of action, and potential physiologic role. Mol Med. 1996;2:597\u2013607.","journal-title":"Mol Med."},{"key":"9679_CR21","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1210\/me.2002-0106","volume":"16","author":"MR Yudt","year":"2002","unstructured":"Yudt MR, Cidlowski JA. The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. J Mol Endocrinol. 2002;16:1719\u201326.","journal-title":"J Mol Endocrinol."},{"key":"9679_CR22","first-page":"37","volume":"21","author":"LK Martin","year":"2009","unstructured":"Martin LK, Werth V, Villanueva E, Segall J, Murrell DF. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev. 2009;21:37\u20139.","journal-title":"Cochrane Database Syst Rev."},{"key":"9679_CR23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI116963","volume":"93","author":"ER Sher","year":"1994","unstructured":"Sher ER, Leung DY, Surs W, Kam JC, Zieg G, Kamada AK, et al. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest. 1994;93:33\u20139.","journal-title":"J Clin Invest."},{"key":"9679_CR24","first-page":"46","volume":"29","author":"SR Antonio De","year":"2002","unstructured":"De Antonio SR, Blotta HM, Mamoni RL, Louzada P, Bertolo MB, Foss NT, et al. Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis. J Rheumatol. 2002;29:46\u201351.","journal-title":"J Rheumatol."},{"key":"9679_CR25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1523-1755.2004.00392.x","volume":"65","author":"AP Carlotti","year":"2004","unstructured":"Carlotti AP, Franco PB, Elias LL, Facincani I, Costa EL, Foss N, et al. Glucocorticoid receptors, in vitro steroid sensitivity, and cytokine secretion in idiopathic nephritic syndrome. Kidney Int. 2004;65:403\u201308.","journal-title":"Kidney Int."},{"key":"9679_CR26","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/ndt\/gfm788","volume":"23","author":"SR Antonio De","year":"2008","unstructured":"De Antonio SR, Saber LTS, Chriguer RS, de Castro M. Glucocorticoid resistance in dialysis patients impairs long-term kidney allograft outcome. Nephrol Dial Transplant. 2008;23:1422\u201328.","journal-title":"Nephrol Dial Transplant."},{"key":"9679_CR27","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1210\/jc.2005-0067","volume":"90","author":"RS Chriguer","year":"2005","unstructured":"Chriguer RS, Elias LL, da Silva Jr IM, Vieira JG, Moreira AC, de Castro M. Glucocorticoid sensitivity in young healthy individuals: in vitro and in vivo studies. J Clin Endocrinol Metab. 2005;90:5978\u201384.","journal-title":"J Clin Endocrinol Metab"},{"key":"9679_CR28","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra032906","volume":"350","author":"NL Olsen","year":"2004","unstructured":"Olsen NL, Stein CM. New drugs for rheumatoid arthritis. N Engl J Med. 2004;350:2167\u201379.","journal-title":"N Engl J Med."},{"key":"9679_CR29","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.186.9.1567","volume":"186","author":"DYM Leung","year":"1997","unstructured":"Leung DYM, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, et al. Association glucocorticoid insensitivity whith increase expression of glucocorticoid receptor \u03b2. J Exp Med. 1997;186:1567\u201374.","journal-title":"J Exp Med."},{"key":"9679_CR30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0960-0760(02)00062-6","volume":"81","author":"RH Derijk","year":"2002","unstructured":"Derijk RH, Schaaf M, De Kloet ER. Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol. 2002;81:103\u201322.","journal-title":"J Steroid Biochem Mol Biol."},{"key":"9679_CR31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.a180","volume":"337","author":"SM Langan","year":"2008","unstructured":"Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study. BMJ. 2008;337:160\u201363.","journal-title":"BMJ."},{"key":"9679_CR32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/archderm.143.7.895","volume":"143","author":"R Rocha-Alvarez","year":"2007","unstructured":"Rocha-Alvarez R, Ortega-Loayza AG, Friedman H, Campbell I, Aoki V, Rivitti EA, et al. Cooperative Group on Fogo Selvagem Research. Endemic pemphigus vulgaris. Arch Dermatol. 2007;143:895\u201399.","journal-title":"Arch Dermatol."},{"key":"9679_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1468-3083.2002.00471.x","volume":"16","author":"AR Ahmed","year":"2002","unstructured":"Ahmed AR, Sami N. Uncommon manifestations of pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2002;16:313\u201315.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"9679_CR34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0001-7310(08)74715-X","volume":"99","author":"R Su\u00e1rez-Fern\u00e1ndez","year":"2008","unstructured":"Su\u00e1rez-Fern\u00e1ndez R, Espa\u00f1a-Alonso A, Herrero-Gonz\u00e1lez JE, Mascar\u00f3-Galy JM. Practical management of the most common autoimmune bullous diseases. Actas Dermosifiliogr. 2008;99:441\u201355.","journal-title":"Actas Dermosifiliogr."},{"key":"9679_CR35","first-page":"4","volume":"13","author":"V Prajapati","year":"2008","unstructured":"Prajapati V, Mydlarski PR. Advances in pemphigus therapy. Skin Therapy Lett. 2008;13:4\u20137.","journal-title":"Skin Therapy Lett."},{"key":"9679_CR36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0378-6323.45235","volume":"75","author":"S Singh","year":"2009","unstructured":"Singh S, Chaudhary R. Pulse therapy for pemphigus: the burden of proof. Indian J Dermatol Venereol Leprol. 2009;75:82\u20134.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"9679_CR37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2133.2011.10663.x","volume":"166","author":"B Horv\u00e1th","year":"2012","unstructured":"Horv\u00e1th B, Huizinga J, Pas HH, Mulder AB, Jonkman MF. Low-dose rituximab is effective in pemphigus. Br J Dermatol. 2012;166:405\u201312.","journal-title":"Br J Dermatol."},{"key":"9679_CR38","doi-asserted-by":"crossref","unstructured":"Behzad M, M\u00f6bs C, Kneisel A, Moeller M, Hoyer J, Hertl M, et al. Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remissions in difficult to treat pemphigus. Br J Dermatol. 2011; Nov 16. doi: 10.1111\/j.1365-2133.2011.10732.x . [Epub ahead of print].","DOI":"10.1111\/j.1365-2133.2011.10732.x"},{"key":"9679_CR39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0016-5085(00)70172-7","volume":"118","author":"M Honda","year":"2000","unstructured":"Honda M, Orii F, Ayabe T, Imai S, Ashida T, Obara T, et al. Expression of glucocorticoid receptor in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology. 2000;118:859\u201366.","journal-title":"Gastroenterology."},{"key":"9679_CR40","doi-asserted-by":"crossref","first-page":"9550","DOI":"10.1074\/jbc.271.16.9550","volume":"271","author":"RH Oakley","year":"1999","unstructured":"Oakley RH, Sar M, Cidlowisk JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem. 1999;271:9550\u201359.","journal-title":"J Biol Chem."},{"key":"9679_CR41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.imbio.2005.11.002","volume":"211","author":"A Goecke","year":"2006","unstructured":"Goecke A, Guerrero J. Glucocorticoid receptor beta in acute and chronic inflammatory conditions: clinical implications. Immunobiology. 2006;211:85\u201396.","journal-title":"Immunobiology."},{"key":"9679_CR42","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1590\/S0100-879X2000000900012","volume":"33","author":"DM Zeoti","year":"2000","unstructured":"Zeoti DM, Figueiredo JFC, Chiossi MPV, Roselino AM. Serum cytokines in patients with Brazilian pemphigus foliaceus (fogo selvagem). Braz J Med Biol Res. 2000;33:1065\u201368.","journal-title":"Braz J Med Biol Res."},{"key":"9679_CR43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000063895","volume":"205","author":"A Baroni","year":"2002","unstructured":"Baroni A, Perfetto B, Ruocco E, Greco R, Criscuolo D, Ruocco V. Cytokine pattern in blister fluid and sera of patients with pemphigus. Dermatology. 2002;205:116\u201321.","journal-title":"Dermatology."},{"key":"9679_CR44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-4362.2001.01083.x","volume":"40","author":"E L\u00f3pez-Robles","year":"2001","unstructured":"L\u00f3pez-Robles E, Avalos-D\u00edaz E, Vega-Memije E, Hojyo-Tomoka T, Villalobos R, Fraire S, et al. TNF\u03b1 and IL-6 are mediators in the blistering process of pemphigus. Inter J Dermatol. 2001;40:185\u201388.","journal-title":"Inter J Dermatol."},{"key":"9679_CR45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5858\/133.1.97","volume":"133","author":"DB Rodrigues","year":"2009","unstructured":"Rodrigues DB, Pereira SA, dos Reis MA, Adad SJ, Caixeta JE, Chiba AM, et al. In situ detection of inflammatory cytokines and apoptosis in pemphigus foliaceus patients. Arch Pathol Lab Med. 2009;133:97\u2013100.","journal-title":"Arch Pathol Lab Med."},{"key":"9679_CR46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cyto.2007.12.007","volume":"41","author":"DB Keskin","year":"2008","unstructured":"Keskin DB, Stern JN, Fridkis-Hareli M. Razzaque Ahmed A. Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy. Cytokine. 2008;41:315\u201321.","journal-title":"Cytokine."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-012-9679-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9679-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:12:09Z","timestamp":1687306329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-012-9679-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,10]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["9679"],"URL":"https:\/\/doi.org\/10.1007\/s10875-012-9679-y","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,10]]}}}